'This is a big problem’: The CRISPR controversy and the ‘mess’ at the heart of the EPO’s appeals boards

A request by CRISPR scientists to withdraw their patents over allegations of mishandling by the EPO’s Boards of Appeals has thrust a ‘fundamentally unfair, uncertain system’ into sharp focus, finds Sarah Speight.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

‘It’s quite unsettling’: How the UPC is changing Europe’s law firms

Media and entertainment lawyer with ‘high-profile’ clients joins Saul Ewing

UPC’s Milan division gears up for ‘unusual case’

Venture capital funding drop of 40% shadows ‘stormy’ global innovation

Battle over sweet traditions: the protection of Ovos Moles de Aveiro

‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute

Jones Day hires former Samsung counsel for NY office

‘It was like starting all over again’: Tobias Wuttke

'This is a big problem’: The CRISPR controversy and the ‘mess’ at the heart of the EPO’s appeals boards

More on this story

Editor's picks

Editor's picks

More articles